ID 159921496 © Oksana Ryzhinskaya | Dreamstime.com
dreamstime_xxl_159921496
June 6, 2025
Foresight Diagnostics announced a strategic, worldwide partnership with QIAGEN to develop and commercialize a kit-based version of Foresight’s CLARITY assay, with the goal...
ID 56463226 © Aviahuismanphotography | Dreamstime.com
dreamstime_xxl_56463226
To take the test online go HERE. For more information, visit the Continuing Education tab. LEARNING OBJECTIVES 1. Discuss current statistics of congenital cytomegalovirus (cCMV...
Courtesy of Randox
logoheader
June 2, 2025
Randox Laboratories announced that the U.S. Food and Drug Administration (FDA) has approved the De Novo application for the company’s first Companion Diagnostic (CDx). The...
ID 181938784 © Douglas Olivares | Dreamstime.com
dreamstime_xxl_181938784_1
May 28, 2025
MD Anderson Cancer Center scientists discovered a new biomarker that can predict “survival outcomes for patients with advanced KRAS G12C-mutated non-small cell ...
ID 342822543 © Rafael Fores | Dreamstime.com
dreamstime_xxl_342822543_1
May 27, 2025
Foresight Diagnostics, Inc. announced the presentation of independent validation data demonstrating the prognostic performance of its Foresight CLARITY MRD assay in patients with...
By LukaszDesign on Adobe Stock
adobestock_801332965
May 23, 2025
QIAGEN announced a new commercial partnership and co-marketing agreement with ID Solutions to expand the availability of dPCR assays for oncology research applications.  ...
ID 355797220 © Dubovdaniilyu | Dreamstime.com
dreamstime_xxl_355797220
May 22, 2025
The global C-reactive protein (CRP) testing market, valued at USD 3.3 billion in 2024, is on a path of steady growth, with projections indicating a compound annual growth rate...
ID 67940812 © Vchalup | Dreamstime.com
dreamstime_xxl_67940812
May 20, 2025
Fujirebio announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the first in vitro diagnostic device that tests blood to aid in diagnosing...
By Keopaserth on Adobe Stock
adobestock_1168120491
May 19, 2025
Roche announced that the U.S. Food and Drug Administration (FDA) has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic approved to aid in determining ...
Courtesy of NIH/NCI
Slides showing minimal disruption (left) and substantial disruption (right) in breast stromal tissue. Courtesy of NIH/NCI.
May 15, 2025
National Institutes of Health (NIH) scientists have uncovered a possible breast cancer biomarker that could help distinguish high risk patients and lead to better prevention and...

Diagnostics

ID 56692654 © Sudok1 | Dreamstime.com
dreamstime_xxl_56692654_1
ID 215927130 © Hulko Svitlana | Dreamstime.com
dreamstime_xxl_215927130
Courtesy of AnalytiChem
2501ana__redipor_an_analytichem_brand__schematic